Published Date: 26 Apr 2023
According to a recent study from The University of Toledo, even at levels that are currently recognized, early exposure to the common class of insecticides known as pyrethroids may increase the risk of autism and other developmental disorders.
Read Full NewsPreschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.
Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.
An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.
In patients with cancer receiving immune checkpoint inhibitor therapy, osteoarthritis is linked to the risk for inflammatory arthritis immune-related adverse events.
Researchers evaluate the impact of allogeneic stem cell transplantation in chronic myelomonocytic leukemia across BLAST and BLAST-Mol clinical risk models.
1.
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer
2.
BlurryScope: A compact, AI-powered microscope for rapid, cost-effective cancer scoring
3.
Drop in credit score after cancer diagnosis linked to increased mortality
4.
Oral drug combination extends progression-free survival in advanced ER-positive breast cancer
5.
Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.
1.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
2.
Essential Updates in Hematology in Daily Practice
3.
Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment
4.
Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines
5.
TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation